IPO Analysis:Anupam Rasayan India Ltd!

By | March 12, 2021 3:33 pm

Highlights of the Company

  • Company is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India (Source: F&S Report). Company commenced business as a partnership firm in 1984 as a manufacturer of conventional products and have, over the years, evolved into custom synthesis and manufacturing of life science related specialty chemicals and other specialty chemicals, which involve multi-step synthesis and complex technologies, for a diverse base of Indian and global customers.
  • The company’s key focus is on developing in-house innovative processes for manufacturing products that require complex chemistries as well as on achieving cost optimization.
  • Company has two distinct business verticals
    (i) life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and
    (ii) other specialty chemicals, comprising specialty pigment and dyes, and polymer additives.
  • Company has developed strong and long-term relationships with various multinational corporations, including, Syngenta Asia Pacific Pte. Ltd., Sumitomo Chemical Company Limited and UPL Limited that has helped them expand their product offerings and geographic reach across Europe, Japan, United States and India. In the nine months ended December 31, 2020, they manufactured products for over 53 domestic and international customer, including 17 multinational companies.
  • Company is also one of the leading companies in manufacturing products using continuous and flow chemistry technology on a commercial scale in India (Source: F&S Report).
  • Company has a dedicated in-house R&D facility and a pilot plant located at Sachin Unit – 6, which is equipped with laboratories engaged in process development, process innovation, new chemical screening and engineering, which assists them in pursuing efficiencies from the initial conceptualization up to commercialization of a product.

Competitive strengths

  • Diversified customer base across geographies and industries.
  • In-house R&D team to foster product innovation.
  • Diversified and customized product portfolio.
  • Strategically located manufacturing facilities.
  • Consistent financial performance track record.

Company Promoters:

Mr. Anand S Desai, Dr. Kiran C Patel, Ms. Mona A Desai, Kiran Pallavi Investments LLC, and Rehash Industrial and Resins Chemicals Private Limited are the company promoters.

The grey market premium on Anupam Rasayan shares last heard is 225-230

Company Financials:

  • Restated Consolidated Total Revenue for the year ended March 31, 2020 INR 5,393.87/- million.
  • Restated Consolidated Profit after tax for the year ended March 31, 2020 INR 529.75/- million.
  • Restated Consolidated Return on Net worth for the year ended on March 31, 2020 is 9.62%.
  • Restated Consolidated Net Asset Value per Equity Share as on March 31, 2020 is Rs.76/-.

Company Name


Offer Period*

12th March to 16th March 2021

Price Band

Rs.553/- to Rs.555/- per equity shares

Lot Size

27 Equity share and multiple of 27 equity share thereafter.

Total Issue Size

Fresh issue of 1,37,15,495 equity shares aggregating up to Rs. 760 crores.

Face Value

Rs.10/- per share.



Who Can Invest

Resident Indian individuals, HUFs, Companies, Corporate Bodies, Scientific Institutions, Societies and Trusts, Eligible NRIs, Category III Foreign Portfolio Investors

Category: IPO Analysis

About Bramesh

Bramesh Bhandari has been actively trading the Indian Stock Markets since over 15+ Years. His primary strategies are his interpretations and applications of Gann And Astro Methodologies developed over the past decade.

Leave a Reply